Artificial intelligence for diagnostics of ALT-positive cancer (AI4CAN)
Dauer: 18 Monate, Fördersumme: € 73.590
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
Dauer: 60 Monate, Fördersumme: € 799.350